Biogen is transitioning from a shrinking MS franchise to a portfolio anchored in rare disease and Alzheimer’s therapies, driving improved mix quality. Learn more about BIIB stock here.

A quick look at the numbers shows us that tokenized real-world assets (RWAs) have exploded mightily over the past 48 months, with the ARK Invest team ...

The global Calibration Services Market is witnessing sustained demand driven by stringent quality standards across manufacturing, healthcare, aerospace, and energy sectors, alongside the rapid ...